Nanotechnology Etf

There was an excellent article discussing the pros and cons of investing in Exchange Traded Funds (ETFs) on July 3 Wall Street Journal: As ETFs Seek niches risks rise (unfortunately, the Wall Street Journal does allow us not link to their articles, maybe that will change after Rupert Murdoch buys Dow Jones.) There are over 500 billion dollars invested in Exchange Traded Funds and I believe they will either replace the funding index variable capital or the strength of these funds reduce their costs. A victory for investors. Exchange traded funds are generally lower on current expenditure, and mutual funds index. You pay a commission to buy or sell, like a stock but the Commission may be less than the fee charged by your broker, or fund the purchase of a mutual fund (consider the class of shares you buy). They are sold, exchanged and schedule, not the end of the day with open-end mutual funds.

ETFs are good vehicles for monitoring different types of investments. You want to invest abroad? In raw materials? Buy Exchange Traded Fund. (Do not get carried away, there are index funds that follow most of the indices that ETFs).

So it's not to love about Exchange Traded Funds? To return to the article in the Wall Street Journal, Lipper, which tracks the performance of the fund, said a disproportionate number of ETFs has shown its losers (misinterpretation) list. For some, it is simply a case of tracking a narrow index and unstable, nanotechnology, for example. The lesson here is that investors need to consider the degree of risk of investment they make. An Exchange Traded Fund does not reduce the risk of technology, commodity volatility, the stock market or an emerging country. What good will does not reflect the performance of whatever index is designed to track her.

Like most new products and Exchange Traded Funds are a new product, there will be risks specific to the product as well. Some will not follow their underlying index due to an overly narrow error or a portfolio. The costs will not automatically less, turnover and taxes are certain issues and to mitigate those risks stick with exchange traded funds issued by well-known institutions.

Vanguard, the godfather of index funds, has joined the party of the ETF and will come with more. (See When a door not a door to find out more about what John Bogle, founder of Vanguard, thinks of them.) Action Vanguard is perhaps the best evidence to date of the rise of ETFs.

The moral of the story is to consider exchange traded funds whenever you consider an index fund or if you want a low cost and liquid way to gain exposure to a particular type of investment. Remember that this does not reduce the risk of the investment class.